Literature DB >> 18408745

T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis.

Andrew Blauvelt1.   

Abstract

T-helper 17 (Th17) cells are a newly appreciated T-cell subset, distinct from both Th1 and Th2 cells, that have been implicated in the pathogenesis of psoriasis and other autoimmune inflammatory diseases (Figure 1) (Fitch et al., 2007; Kastelein et al., 2007). IL-23 stimulates survival and proliferation of Th17 cells and thus serves as a key master cytokine regulator for these diseases.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18408745      PMCID： PMC2885349          DOI： 10.1038/jid.2008.85

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


  23 in total

1.  The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis.

Authors:  Susan M Sa; Patricia A Valdez; Jianfeng Wu; Kenneth Jung; Fiona Zhong; Linda Hall; Ian Kasman; Jane Winer; Zora Modrusan; Dimitry M Danilenko; Wenjun Ouyang
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

2.  Polymorphisms of the IL12B and IL23R genes are associated with psoriasis.

Authors:  Rajan P Nair; Andreas Ruether; Philip E Stuart; Stefan Jenisch; Trilokraj Tejasvi; Ravi Hiremagalore; Stefan Schreiber; Dieter Kabelitz; Henry W Lim; John J Voorhees; Enno Christophers; James T Elder; Michael Weichenthal
Journal:  J Invest Dermatol       Date:  2008-01-24       Impact factor: 8.551

3.  IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection.

Authors:  Euan Lockhart; Angela M Green; JoAnne L Flynn
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

4.  In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.

Authors:  Gamze Piskin; Regien M R Sylva-Steenland; Jan D Bos; Marcel B M Teunissen
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

5.  A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes.

Authors:  Michele Cargill; Steven J Schrodi; Monica Chang; Veronica E Garcia; Rhonda Brandon; Kristina P Callis; Nori Matsunami; Kristin G Ardlie; Daniel Civello; Joseph J Catanese; Diane U Leong; Jackie M Panko; Linda B McAllister; Christopher B Hansen; Jason Papenfuss; Stephen M Prescott; Thomas J White; Mark F Leppert; Gerald G Krueger; Ann B Begovich
Journal:  Am J Hum Genet       Date:  2006-12-21       Impact factor: 11.025

6.  IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis.

Authors:  Kerstin Wolk; Ellen Witte; Elizabeth Wallace; Wolf-Dietrich Döcke; Stefanie Kunz; Khusru Asadullah; Hans-Dieter Volk; Wolfram Sterry; Robert Sabat
Journal:  Eur J Immunol       Date:  2006-05       Impact factor: 5.532

7.  A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

Authors:  Gerald G Krueger; Richard G Langley; Craig Leonardi; Newman Yeilding; Cynthia Guzzo; Yuhua Wang; Lisa T Dooley; Mark Lebwohl
Journal:  N Engl J Med       Date:  2007-02-08       Impact factor: 91.245

8.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides.

Authors:  Spencer C Liang; Xiang-Yang Tan; Deborah P Luxenberg; Riyez Karim; Kyriaki Dunussi-Joannopoulos; Mary Collins; Lynette A Fouser
Journal:  J Exp Med       Date:  2006-09-18       Impact factor: 14.307

9.  Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris.

Authors:  Edmund Lee; William L Trepicchio; Judith L Oestreicher; Debra Pittman; Frank Wang; Francesca Chamian; Madhav Dhodapkar; James G Krueger
Journal:  J Exp Med       Date:  2004-01-05       Impact factor: 14.307

10.  IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis.

Authors:  Jason R Chan; Wendy Blumenschein; Erin Murphy; Caroline Diveu; Maria Wiekowski; Susan Abbondanzo; Linda Lucian; Richard Geissler; Scott Brodie; Alexa B Kimball; Daniel M Gorman; Kathleen Smith; Rene de Waal Malefyt; Robert A Kastelein; Terrill K McClanahan; Edward P Bowman
Journal:  J Exp Med       Date:  2006-10-30       Impact factor: 14.307
View more
  46 in total

1.  Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice.

Authors:  N L Ward; C M Loyd; J A Wolfram; D Diaconu; C M Michaels; T S McCormick
Journal:  Br J Dermatol       Date:  2011-04       Impact factor: 9.302

2.  Development of a bioengineered skin-humanized mouse model for psoriasis: dissecting epidermal-lymphocyte interacting pathways.

Authors:  Sara Guerrero-Aspizua; Marta García; Rodolfo Murillas; Luisa Retamosa; Nuria Illera; Blanca Duarte; Almudena Holguín; Susana Puig; Maria Isabel Hernández; Alvaro Meana; Jose Luis Jorcano; Fernando Larcher; Marta Carretero; Marcela Del Río
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

3.  Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells.

Authors:  Sayaka Shibata; Yayoi Tada; Carren Sy Hau; Aya Mitsui; Masahiro Kamata; Yoshihide Asano; Makoto Sugaya; Takafumi Kadono; Yosuke Masamoto; Mineo Kurokawa; Toshimasa Yamauchi; Naoto Kubota; Takashi Kadowaki; Shinichi Sato
Journal:  Nat Commun       Date:  2015-07-15       Impact factor: 14.919

4.  Effect of interleukin-17 on receptor-interacting protein 4 expression and keratinocyte proliferation.

Authors:  Kun Jia; Yan Zhang; Weiyuan Ma; Xiaofeng Zhang; Qing Sun
Journal:  Exp Ther Med       Date:  2015-05-07       Impact factor: 2.447

Review 5.  Skin immunity and its dysregulation in psoriasis.

Authors:  Caterina Lanna; Mara Mancini; Roberta Gaziano; Maria Vittoria Cannizzaro; Marco Galluzzo; Marina Talamonti; Valentina Rovella; Margherita Annicchiarico-Petruzzelli; Gerry Melino; Ying Wang; Yufang Shi; Elena Campione; Luca Bianchi
Journal:  Cell Cycle       Date:  2019-08-15       Impact factor: 4.534

Review 6.  CCR6 as a possible therapeutic target in psoriasis.

Authors:  Michael N Hedrick; Anke S Lonsdorf; Sam T Hwang; Joshua M Farber
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

7.  Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes.

Authors:  Yuangang Liu; James P Lagowski; Shangpu Gao; James H Raymond; Clifton R White; Molly F Kulesz-Martin
Journal:  J Invest Dermatol       Date:  2010-01-07       Impact factor: 8.551

8.  Potential role of ustekinumab in the treatment of chronic plaque psoriasis.

Authors:  Santo Raffaele Mercuri; Luigi Naldi
Journal:  Biologics       Date:  2010-05-25

9.  Update of the management of chronic psoriasis: new approaches and emerging treatment options.

Authors:  Philip M Laws; Helen S Young
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-04-21

10.  T-helper 17 lymphocytes in ocular cicatricial pemphigoid.

Authors:  Alessandro Lambiase; Alessandra Micera; Flavio Mantelli; Caterina Moretti; Antonio Di Zazzo; Eleonora Perrella; Sergio Bonini; Stefano Bonini
Journal:  Mol Vis       Date:  2009-07-28       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.